April 16, 2019
Daiichi Sankyo rolled out its peripheral neuropathic pain treatment Tarlige (mirogabalin) in Japan on April 15, pitting it against Pfizer’s Lyrica (pregabalin) to vie for a slice of its near-100 billion yen market in the country. Tarlige is a calcium...read more